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Abstract
Apolipoprotein E (apoE) and the low density lipoprotein receptor (LDLr) are well recognized 
determinants of atherosclerosis. In addition to hepatocytes, where both are highly expressed and 
contribute to plasma lipoprotein clearance, they are expressed in vascular cells and macrophages. 
In this study, we examined the effects of human apoE isoforms and LDLr levels in atherogenic 
pathways in primary macrophages ex vivo and atherosclerosis development after bone marrow 
transfer in vivo using mice expressing human apoE isoforms and different levels of LDLr 
expression. Increases in LDLr expression significantly increased cholesterol delivery into 
macrophages in culture, and the effects were more prominent with lipoproteins containing apoE4 
than those containing apoE3. Conversely, increased LDLr expression reduced cholesterol efflux in 
macrophages expressing apoE4 but not in macrophages expressing apoE3. Furthermore, apoE3 
protected VLDL from oxidation in vitro more than did apoE4. In LDLr-deficient mice expressing 
the human apoE4 isoform, Apoe4/4 Ldlr−/−, the replacement of bone marrow cells with those 
expressing LDLr increased atherosclerotic lesions in a dose-dependent manner compared with 
mice transplanted with cells having no LDLr. In contrast, atherosclerosis in Apoe3/3 Ldlr−/− mice, 
expressing the human apoE3 isoform, did not differ by the levels of macrophage LDLr expression. 
Our results demonstrate that apoE4, but not apoE3, in macrophages enhances atherosclerotic 
plaque development in mice in an LDLr-dependent manner and suggests that this interaction may 
contribute to the association of apoE4 with an increased cardiovascular risk in humans.
Elevated levels of cholesterol in plasma, carried by remnant particles of very low density 
lipoproteins (VLDL)3 and low density lipoproteins (LDL), are well known risk factors for 
atherosclerosis. The bulk of these atherogenic lipoproteins are cleared from the circulation 
by the LDL receptor (LDLr) in the liver with apolipoprotein E (apoE) and apoB100 as 
ligands. There are three common apoE isoforms in humans: apoE2, apoE3, and apoE4, each 
having distinct influences on both lipid metabolism and atherogenesis in humans (1). 
Possession of at least one copy of the APOE*2 allele is associated with higher plasma apoE 
and triglyceride but lower LDL cholesterol levels and atherosclerosis risk when compared 
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with APOE*3 homozygotes (1). In contrast, the presence of at least one APOE*4 allele is 
associated with lower plasma apoE, increased LDL cholesterol, and a greater risk of 
coronary artery disease than APOE*3 homozygotes. This association is thought to be mainly 
due to differences in lipoprotein clearance and is counterintuitive, considering the LDLr 
affinity of apoE2 is lower while the affinity of apoE4 is slightly higher than apoE3 (2, 3).
To gain insights into the mechanisms underlying the relationship between atherosclerosis 
risk and apoE isoform in humans, we previously made mice expressing human apoE2, 
apoE3, or apoE4 in place of the endogenous mouse apoE (3–5). Notably, the atherosclerosis 
risk associated with the resulting mice was different from that in humans; mice with apoE2 
had increased plasma lipids and developed atherosclerosis, whereas mice with apoE3 and 
apoE4 were normolipidemic and resistant to atherosclerosis. To further test whether the 
apoE isoform-dependent atherosclerosis risk is affected by the LDLr expression, we also 
developed mice in which the endogenous mouse Ldlr gene was replaced with a gene (hLdlr) 
coding for human LDLr. The transcriptional regulation of the hLdlr gene was normal, but 
the steady state levels of its mRNA in the liver were elevated, because the transcripts carry a 
more stable 3′-untranslated region sequence than normal. Somewhat unexpectedly, we 
found that, when this hLdlr allele was introduced into mice expressing human apoE 
isoforms, physiologic overexpression of the LDLr was protective in mice with apoE2 but 
caused severe atherosclerosis in mice with apoE4, recapitulating the associations between 
apoE isoforms and atherosclerosis risk seen in humans (6,7). These data suggest that the 
LDLr apoE interaction is central to the increased atherosclerosis risk associated with apoE4.
A substantial portion of the atherosclerosis risk associated with apoE4 is probably due to its 
hepatic metabolism by the LDLr and the resultant changes to plasma lipids. However, there 
is ample in vitro evidence that the interaction of apoE with the LDLr in the liver may not be 
entirely responsible for the risk of coronary artery disease associated with apoE4 in humans 
(8–10). Both ApoE and the LDLr are expressed in many cell types and are thought to play 
roles in the atherosclerotic process beyond their role in lipoprotein clearance (11). The 
effects on atherogenesis of apoE isoforms and levels of LDLr in extrahepatic tissues (e.g. in 
macrophages) are difficult to study in vivo, because their combined effects on plasma lipids 
are confounding.
Herein, we address the effect of LDLr expression level and human apoE3 and apoE4 
isoforms on lipoprotein uptake and efflux in macrophages isolated from mice having human 
apoE isoforms and different levels of LDLr expression. We also examined in vivo whether 
the interactions between apoE and LDLr in macrophages, independent of global LDLr 
expression, affect atherosclerosis after bone marrow transfer (BMT) in mice expressing 
human apoE3 or apoE4 and lacking LDLr (3ko or 4ko) (12). We found that the expression of 
LDLr in macrophages directly correlated with the extent of atherosclerosis in mice with 
human apoE4. In contrast, macrophage LDLr expression did not affect atherosclerosis in 
mice expressing apoE3. These results indicate that apoE4 exerts adverse effects on bone 
marrow-derived cells in the vessel wall in an LDLr-dependent manner and may contribute to 
its pathogenesis.
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All the mutant mouse strains used in this work were individually backcrossed at least 6 
generations to C57BL/6 genetic background before intercrossing. Mice heterozygous for a 
targeted replacement of the mouse Ldlr gene with the stabilized human Ldlr minigene 
(Apoe+/+Ldlrh/+) (13) were bred to mice homozygous for replacement of the mouse apoE 
gene with either the human APOE*3 or APOE*4 allele (Apoe3/3Ldlr+/+ and Apoe4/4Ldlr+/+) 
(3,5). The littermates generated by crossing Apoe3/3Ldlr+/+ (3m) with Apoe3/3Ldlrh/+ (3h) 
and Apoe4/4Ldlr+/+ (4m) with Apoe4/4Ldlrh/+ (4h), respectively, were used in experiments as 
donors of bone marrow cells. Mice with human APOE*3 and lacking LDLr (3ko) and mice 
with human APOE*4 and lacking LDLR (4ko) were generated by crossing either Apoe3/3 or 
Apoe4/4 mice with Ldlr−/− mice (6) and maintained as Apoe3/3 Ldlr−/− (3ko) or Apoe4/4 
Ldlr−/− (4ko), respectively (see Table 1 for genotypes and nomenclature). Mice were fed 
either normal mouse chow containing 4.5% (w/w) fat and 0.022% (w/w) cholesterol (Prolab 
RMH 3000; Agway Inc.) or a high fat Western-type (HFW) diet containing 21% (w/w) fat 
and 0.2% (w/w) cholesterol (TD88137; Teklad). The animals were handled under protocols 
approved by the Institutional Animal Care and Use Committees of the University of North 
Carolina (Chapel Hill, NC).
Peritoneal Macrophage Isolation
Macrophages (MPM) were obtained from the peritoneal cavity of mice 4 days after 
intraperitoneal injection of 1 ml of 4% (w/v) thioglycolate (BD Biosciences). The cells 
obtained were either directly used for gene expression analyses (below) or washed with 
Ham's nutrient mixture F-10 medium (F-10), spun at 1000 × g for 5 min, and plated in 12-
well plates at a density of 6 × 105 cells/well in F-10 medium supplemented with 10% fetal 
bovine serum, 100 units/ml penicillin, 100μg/ml streptomycin, and 2 mM L-glutamine. Cells 
were washed 2 h later to remove nonadherent cells. Cells were cultured in medium without 
fetal bovine serum for 24 h prior to experiments.
Lipoprotein Uptake
LDL was isolated from human plasma as described (7). Mouse VLDL fractions enriched 
with human apoE3 or apoE4 were isolated from pooled plasma of 3ko or 4ko mice, 
respectively, by ultracentrifugation at d < 1.006. Lipoproteins were labeled with 1,1′-
dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate (DiI C18; Molecular Probes, 
Inc., Eugene, OR), as described by Stephan and Yurachek (14). Macrophages in culture were 
washed and incubated in F-10 medium without fetal bovine serum for 24 h, followed by 
incubation with medium containing 1 μg/ml of DiI-labeled human LDL or mouse VLDL. 
After 2 h, cells were washed with fresh medium, and fluorescence was observed with an 
IX70 inverted microscope (Olympus) equipped with a filter set for Texas red (exciter 
560/55, dichroic 595, emitter 645/75; Chroma Technology Corp.). Fluorescence pixel 
intensity of each cell was recorded with a SPOT RT Slider digital camera and analyzed with 
SPOT version 4.0.9 (Diagnostic Instruments) and ImageJ 1.33u software (National Institutes 
of Health).
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MPM were cultured 24 h in F-10 medium without fetal bovine serum. Cells were 
radiolabeled by incubating with 2 μCi/ml [3H]cholesterol (PerkinElmer Life Sciences) for 24 
h. They were then washed and further incubated for 24 h with F-10 medium with or without 
10 μg/ml of apolipoprotein A-I (apoA-I) protein (Sigma). Following incubation, medium 
was removed, spun at 12,500 × g for 15 min, and assayed for radioactivity. Cells were 
washed with ice-cold PBS, and lipids were extracted with isopropyl alcohol for 4 h and 
assayed for radioactivity. Radiolabel in the medium and the cellular isopropyl alcohol extract 
was measured, and percentage effluxed was calculated as the ratio of radioactivity in the 
medium divided by the total (cells + medium). To analyze efflux of cholesterol from 
cholesterol-loaded foam cells, MPM were incubated with acetylated human LDL (AcLDL) 
and 2 μCi/ml [3H]cholesterol for 24 h, and efflux was measured after 16 h. LDL (density 
1.019–1.063 g/ml) was acetylated by acetic anhydride (15).
Western Blot
To measure ApoE protein content, MPM in culture were washed and cultured in lipid-free 
F-10 medium. After 24 h, the amount of apoE protein associated with cells and in the 
medium was measured using Western blot with an antibody against human apoE 
(Calbiochem). Protein loading was controlled by the amount of tubulin using anti-tubulin 
antibody (Sigma), and gel to gel control for densitometric analysis was done with a standard 
amount of apoE.
Oxidative Stress
VLDL (1 μg of protein) from the 3ko or 4ko mice was incubated with 10 μM CuSO4 as 
described (16). Oxidation and the increase in the formation of conjugated dienes were 
measured by recording their absorbance at 234 nm every 20 min for 3 h. The lag time was 
determined graphically. Amounts of thiobarbituric acid-reactive substances (TBARS) in 
plasma, VLDL, and cultured medium were assayed as described (16). MPM were cultured 
with VLDL isolated from apoE-deficient mice (50 μg/ml of F-10 medium) for 24 h. 
Oxidized VLDL was prepared by incubating VLDL in μM CuSO4 for 24 h.
Gene Expression
RNA was extracted from MPM using RNAeasy kit (Qiagen, Valencia, CA) according to the 
manufacturer's protocol, either directly from peritoneal cells of mice that underwent BMT or 
cultured MPM from mice fed the HFW diet. Cultured macrophage cells were incubated with 
F-10 medium or F-10 medium plus 50 μg/ml apoE-deficient VLDL for 16 h. Real time RT-
PCR amplifications (8) were performed in a 96-well plate in the ABI Prism 7700 sequence 
detector (PE Biosystems) in a total volume of 30 μl, which included 10 μl of RNA sample 
from the ABI Prism 6700 plus 20 μl of a reaction mixture. Each RT-PCR amplification was 
performed in duplicate: 30 min at 48 °C for the RT reaction and then 10 min at 94 °C, 
followed by a total of 40 temperature cycles (15 s at 94 °C and 1 min at 60 °C). To 
determine total Ldlr mRNA levels, a primer probe system specific for murine exon 1, which 
is also present in mice targeted for the hLdlr, was used (13).
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Bone marrow cells were collected from the femurs and tibias of donor male mice by 
flushing with F-10 medium. Recipient female mice, 6–8 weeks of age, were lethally 
irradiated (9.5 grays) and injected with 2 × 106 bone marrow cells in 0.2 ml of medium 
through tail veins. For 2 weeks after transplantation, mice were given drinking water 
acidified to pH 2.0 by HCl and containing 100 mg/liter neomycin. Mice were fed an HFW 
diet for 3 months.
Plasma Lipids, Lipoprotein Analysis
Plasma was isolated, and total cholesterol (free and esterified) and triglycerides were 
measured as described previously (6). Lipoprotein distribution in pooled plasma samples 
(100 μl) was analyzed by fast protein liquid chromatography using a Superose 6 HR10/30 
column (Amersham Biosciences).
Evaluation of Atherosclerotic Lesions
BM recipient mice were fed an HFW diet for 12 weeks before sacrifice. Mice were perfused 
through the apex of the left ventricle with 4% paraformaldehyde under physiological 
pressures. Segments of the aortic sinus were embedded and sectioned, and the size of 
atherosclerotic plaques in aortic roots were scored as described previously (17).
Statistical Analysis
The statistical significance of genotype effects were analyzed by using analysis of variance 
(JMP software; SAS Inc., Cary, NC). Tukey-Kramer HSD was used for post hoc pairwise 
comparisons.
Results
Down-regulation of the LDLr Expression by Lipid in Macrophages
Our previous work (6, 13) showed that the 3′-untranslated region modification within the 
hLdlr allele made its transcripts in the liver more stable than the normal mouse allele, but the 
hLdlr allele retained the transcriptional repression in response to dietary cholesterol intake. 
To test whether the expression of the hLdlr allele is also normally regulated in macrophages 
by exogenous lipid, we isolated MPM from 3m, 3h, 4m, and 4h mice (see Table 1) and 
placed them in culture. Both 3h and 4h MPM cells cultured for 16 h without VLDL had 
higher LDLr expression than 3m and 4m MPM cells by ∼3–4–fold (Fig. 1, p ≤ 0.0001). The 
levels of Ldlr mRNA decreased in all MPM cells when they were incubated with apoE-
deficient VLDL for 16 h, and the decrease was proportional whether cells had wild type or 
elevated LDLr. However, cells with apoE4 had greater proportional decreases in LDLr 
expression compared with cells with apoE3. Thus, the hLdlr gene in macrophages retains its 
normal feedback response to increased intracellular lipid and can be down-regulated by high 
levels of lipid, but its transcripts remain 2–3-fold higher than the wild type Ldlr mRNA.
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LDLr Expression and Lipoprotein Uptake in Macrophages
To test whether increased expression of the LDLr in macrophages increases uptake of 
lipoproteins we isolated MPM from 4ko, 4m, and 4h mice and incubated them with DiI-
labeled human LDL in culture. After 2 h, intracellular fluorescent intensity in 4h 
macrophages was twice that of 4m macrophages and three times higher than 4ko cells (Fig. 
2A), demonstrating that the LDL uptake by macrophages directly correlates with LDLr 
expression. In hyperlipidemic mice, as well as humans, lipoprotein particles accumulate not 
only in LDL fractions but also in VLDL fractions. For example, in the plasma of LDLr−/− 
mice with human apoE, VLDL particles are enriched with cholesterol and triglyceride, as 
well as apoE protein (7). We therefore incubated the MPM with VLDL fractions enriched in 
apoE3 or apoE4 from 3ko and 4ko mice. Uptake of the mouse apoE3-enriched VLDL 
particles by 3h MPM was modestly but significantly increased compared with that by 3ko 
MPM (9%, p = 0.02; Fig. 2B). Uptake of apoE3-enriched VLDL by the 4h MPM was not 
different from the uptake by the 4m MPM. In marked contrast, both 3h and 4h MPM 
incorporated significantly more apoE4-enriched VLDL than 3ko and 4ko MPM (33% (p ≤ 
0.0001) and 26% (p ≤ 0.0001), respectively) (Fig. 2C). This suggests that the apoE isoform 
present on the VLDL particle and the LDLr in the macrophages, but not macrophage apoE, 
influences uptake and that apoE4 in the particles promotes VLDL uptake more than apoE3. 
Taken together, the data suggest that increased LDLr in macrophages by mRNA stabilization 
causes increased uptake of LDL particles as well as VLDL particles, and the VLDL uptake 
would be more pronounced when the particles contain apoE4 rather than apoE3.
Effects of ApoE4 and LDLr Expression on Cholesterol Efflux from Macrophages
To examine whether the different apoE isoforms facilitate cholesterol efflux from 
macrophages differently and whether the effect is dependent on the levels of LDLr 
expression in macrophages, we measured cholesterol efflux from MPM isolated from mice 
expressing human apoE isoforms with high levels of LDLr (3h and 4h) or without LDLr 
(3ko and 4ko). In unloaded cells expressing apoE3, cholesterol efflux was not influenced by 
the LDLr expression when cells were incubated without apoA-I. In contrast, the LDLr 
expression had a significant effect when cells expressed apoE4, and the efflux from the 4h 
cells was 30% less than from 4ko cells (p ≤ 0.0005; Fig. 3A). The addition of apoA-I to the 
culture medium increased cholesterol efflux from cells regardless of apoE isoforms (Fig. 
3B). ApoA-I-mediated efflux from the 4h cells with elevated expression of LDLr was 
significantly higher than 4ko cells not expressing LDLr. The difference was larger and 
significant between 4ko and 4h cells (p < 0.003) than between 3ko and 3h cells (not 
significant). In contrast, efflux of cholesterol from cholesterol-loaded foam cells after 
incubation with AcLDL depended on LDLr but not on apoE genotype (Fig. 3C). These data 
demonstrate that the LDLr expression in macrophages influences the cholesterol efflux in an 
apoE isoform-dependent fashion when macrophages are cultured in lipid-free medium and 
suggest that both apoE isoform and LDLr expression may be important determinants for 
foam cell formation. However, when cells were loaded with AcLDL, apoE isoform effects 
were no longer detectable.
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ApoE Secretion from Cultured MPM
To address whether cholesterol efflux is related to the intracellular levels of apoE isoforms, 
we examined the apoE contents associated with cells and in medium 24 h after culturing in 
lipid-free F-10 medium by Western blot analysis. The intracellular apoE contents in both 3h 
and 4h cells were consistently higher than in 3ko and 4ko cells (Fig. 3D). Similarly, apoE 
protein contents in culture medium of 3ko and 4ko cells were lower than those of 3h and 4h 
cells. Relative amounts between apoE3 cells and apoE4 cells somewhat varied culture by 
culture and were not consistently different. We conclude that LDLr expression in MPM 
significantly affects apoE uptake and secretion and probably influences the cholesterol 
efflux.
VLDL Oxidation
We next tested whether lipoprotein oxidation in our mice is apoE isoform-dependent, which 
may be due to the free cysteinyl groups on apoE3 and apoE2 (9, 16). ApoE2 has two free 
cysteinyl groups, and apoE3 has one, and both have been shown to function as a better 
antioxidant than apoE4 protein, which has no free cysteinyl group. We isolated human apoE-
enriched VLDL particles from 2ko, 3ko, and 4ko mice and tracked conjugated diene 
formation during Cu2+-mediated oxidation of these lipoprotein particles. The lag time for 
conjugated diene formation was 24 min in VLDL isolated from 4ko mice compared with 49 
min in VLDL from 3ko mice and the longest, 70 min, in 2ko VLDL (Fig. 4A). Measurement 
of TBARS after overnight oxidation showed that apoE4-VLDL contained 3-fold more 
TBARS than did apoE3-VLDL (Fig. 4B).
To test whether expression of LDLr in macrophages influences VLDL oxidation in an apoE-
dependent manner, we next cultured MPM in medium with apoE-deficient VLDL for 24 h 
and measured TBARS in medium as an indicator for oxidized lipids. The amounts of 
TBARS were borderline detectable and were slightly higher in medium cultured with apoE4 
macrophages than with apoE3 and lower with elevated LDLr than with no LDLr, but neither 
apoE genotype nor LDLr had statistically significant effects by two-way analysis of 
variance. These data suggest that the apoE4 isoform does not protect lipoprotein particles 
from oxidation as well as apoE3 when a strong oxidative stress is applied in vitro. However, 
effects of apoE isoforms in macrophages on oxidation in culture are not significant, even 
under conditions of elevated triglycerides and cholesterol. In addition, we did not detect any 
statistical differences in the amount of TBARS or GSH in the plasma of 3ko and 4ko 
recipient mice (data not shown).
BMT and Plasma Lipids
The experiments above indicate that apoE4 proves to be impaired relative to apoE3 in 
several pathways important to lipid homeostasis in macrophages and perhaps atherosclerosis 
lesion formation, and the effects are influenced by the levels of LDLr expression in 
macrophages. To test whether the observed differences could alter overall atherogenesis in 
vivo, we carried out BMT in mice lacking LDLr but expressing human apoE3 (3ko) or 
apoE4 (4ko). To alter macrophage expression of LDLr, 3ko or 4ko females were lethally 
irradiated and transplanted with BM isolated from male mice with the same ApoE genotype, 
having no LDLr (3ko, 4ko), wild type LDLr (3m, 4m), or elevated expression of LDLr (3h, 
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4h). Three months after BMT, PCR of the Ldlr gene in the blood cells of the recipient 
animals showed only the products corresponding to the genotype of the donor cells, and no 
visible products corresponding to the recipient genotype (ko) were detected in the mice that 
received m or h BM cells (Fig. 5A). This confirmed that the replacement of the BM-derived 
cells in the recipients by the donor cells was probably complete. The total Ldlr mRNA levels 
in the peritoneal cells isolated from representative recipient mice showed that the 
macrophages in the 3ko mice receiving 3h BM cells had 4-fold higher Ldlr gene expression 
than the macrophages in the 3ko mice receiving 3m BM cells. Similarly, total expression of 
the Ldlr gene in macrophages from the 4ko mice receiving 4h BM cells was 4-fold higher 
than in those receiving 4m cells (Fig. 5B). Thus the levels of Ldlr mRNA in mice that 
received 3h or 4h bone marrow are elevated compared with those in mice that received wild 
type LDLr to similar degrees as the MPM cells in culture as shown in Fig. 1A
Feeding HFW diet increased plasma cholesterol levels ∼3-fold in both 3ko and 4ko mice 
regardless of donor Ldlr genotype (Table 2). Both 3ko and 4ko mice have elevated 
cholesterol in VLDL fractions as well as LDL fractions. HDL-cholesterol were very low in 
both 3ko and 4ko mice on HFW diet, and the plasma apoA-I levels were not different 
between them (not shown). The transfer of bone marrows with differing expression levels of 
LDLr did not cause any significant changes in plasma lipoprotein distribution in either the 
3ko or 4ko mice by fast protein liquid chromatography analyses (Fig. 5C). We conclude that 
the increased macrophage LDLr expression is not sufficient to alter plasma VLDL clearance 
in the LDLr−/− mice with apoE3 or apoE4. Consistent with previous work, the LDLr 
expression in BM-derived cells had no influence over plasma lipid profiles (18).
Macrophage LDLr Expression and Atherosclerosis in Mice with ApoE4
Both 3ko and 4ko mice develop lesions in the aortic sinus as summarized in Table 3. 
Feeding the recipient mice with the HFW diet for 12 weeks increased atherosclerotic plaque 
size in both 3ko and 4ko mice that received either control 3ko or 4ko BM. There were no 
significant apoE genotype effects on the lesion area (346 ± 19 × 103 μm2 (n = 12) in 3ko 
versus 386 ± 28 × 103 μm2 (n = 14) in 4ko, p = 0.3) (Fig. 6).
We also found no change in the lesion area of 3ko mice as macrophage LDLr level increased 
(Fig. 6). Thus, 3ko mice that received 3m and 3h BM had a mean area of 356 ± 28 × 103 
μm2 (n = 13) and 338 ± 28 × 103 μm2 (n = 13), respectively (p = 0.9). In contrast, 4ko mice 
developed larger lesions as their macrophages expressed increasing amounts of LDLr. Thus, 
4ko mice that received 4m BM and 4h BM had mean lesion areas of 459 ± 41 × 103 μm2 (n 
= 15) and 511 ± 34 × 103 μm2 (n = 13), respectively. The difference between the lesion sizes 
in mice that received 4h donor cells and 4ko donor cells was significant (p ≤ 0.05). When all 
six groups were analyzed together, the difference in atherosclerosis between 3ko mice with 
3h BM and 4ko mice with 4h BM was also significant (p ≤ 0.01).
Taken together, our data demonstrate that there is an interaction between the apoE genotype 
and LDLr expression of macrophages in determining atherosclerosis development. In the 
LDLr−/− mice, increased expression of LDLr in BM-de-rived cells has no effect when 
animals are expressing apoE3, whereas it is detrimental in mice expressing apoE4.
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Gene Expression in the Peritoneal Macrophages of Mice after BMT
To gain insight into the mechanism of the interaction between macrophage LDLr expression 
and apoE expression in atherosclerosis development, we isolated MPM from mice receiving 
BM transfer 4 days after stimulation with thioglycollate. Quantitative RT-PCR of peritoneal 
cells showed that the expression of genes coding for MCP1 (monocyte chemotactic 
protein-1), CD36, LDLr, apoE, and SR-A (scavenger receptor A) were not significantly 
different among recipients who received the donor cells with different LDLr levels (Table 4). 
Thus, the effect of apoE4 isoform and LDLr level in atherogen-esis does not appear to 
involve pathways affecting expression of MCP1, CD36, or SR-A in macrophages. In 
contrast, ABCA1 expression was increased in MPM that expressed elevated LDLr compared 
with ko MPM regardless of apoE genotype, although the increase was statistically 
significant only in 3h cells compared with 3ko cells. The up-regulation of ABCA1 in 3h and 
4h macrophages may indicate higher intracellular cholesterol content in these cells relative 
to 3ko and 4ko cells (19, 20). This is also consistent with an increased cholesterol efflux 
from 3h and 4h macrophages compared with 3ko and 4ko macrophages when exogenous 
apoA-I acceptor protein is given to the culture (Fig. 3B).
Discussion
ApoE, as a ligand for the removal of lipoproteins, is generally considered atheroprotective; 
however, the extent to which this depends on its isoform, concentration, and location (1, 
21-23) is not known. In this study, we tested the interaction of apoE isoforms with LDLr on 
several atherosclerosis pathways in macrophages. We then used BMT in mice to investigate 
whether their interaction in macrophages affect atherosclerosis development. Our results 
showed that expression of macrophage LDLr in the presence of apoE4 enhanced 
atherosclerosis. In contrast, these same LDLr increases in mice with apoE3 did not affect 
atherosclerosis. Thus, our results demonstrate, for the first time in animal models, that some 
of the risk associated with human apoE4 isoform may be due to its interaction with the 
LDLr in macrophages as well as with hepatic LDLr.
We found that apoE isoforms expressed by the macrophages had only a modest, 
nonsignificant effect on apoA-I-stimulated cholesterol efflux from MPM but that the levels 
of LDLr expressed by the macrophages significantly increased apoA-I-assisted cholesterol 
efflux from apoE4 macrophages and less so from apoE3 macrophages. Cholesterol efflux, 
when apoA-I was not present, was generally low but affected by LDLr expression only in 
apoE4 macrophages and in an inverse direction. Thus, high LDLr expression did not alter 
efflux from macrophages with apoE3 but significantly inhibited efflux from macrophages 
with apoE4. A likely explanation for this is that apoE4 is more efficient than apoE3 for 
capturing and reuptake of cholesterol containing particles by macrophages. Alternatively, the 
possible increased amount of intracellular apoE4 compared with apoE3 may retard 
cholesterol secretion with the endogenous apoE, thus yielding the apparent difference in 
efflux. In contrast, in cholesterol-loaded foam cells, high LDLr expression inhibited efflux in 
both apoE3 and apoE4 macrophages. The interaction between LDLr and apoE4 resulted in 
significant effects only in unloaded cells in which LDLr expression is high. The difference 
in efflux between apoE3 and apoE4 is small in loaded foam cells, in which expression of 
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LDLr is down-regulated. In the present work, we observed that cultured MPM expressing 
LDLr have more cell-associated apoE than MPM without LDLr regardless of apoE 
genotype. Nevertheless, the difference between apoE3 and apoE4 in intracellular trafficking 
and accumulation has been established (24) and may be contributing to the difference in 
cholesterol efflux. Supporting this possibility, we reported earlier, in collaboration with Dr. 
Mazzone and colleagues at the University of Illinois, that MPM with increased LDLr 
expression showed reduced apoE secretion compared with MPM with basal LDLr 
expression and that the relative reduction was greater with apoE4 than with apoE3. Further 
studies are necessary to elucidate the possible relationships between cholesterol efflux and 
intracellular localization of apoE3 and apoE4 in MPM (25).
Increased cholesterol uptake increases ABCA1 expression and efflux to acceptor proteins 
(19,20). Thus, we observed that macrophages isolated from Ldlr−/− mice receiving BM cells 
with high Ldlr gene expression showed elevated ABCA1 expression. This increase in 
ABCA1 expression probably accounts for the increased apoA-I-mediated cholesterol efflux 
in the presence of LDLr in macrophages. In addition, the presence of a large amount of 
apoA-I could interfere with the apoE-mediated reuptake of lipid particles. Our observation 
of iso-form-specific effects of apoE on cholesterol efflux is consistent with previous reports 
by other investigators. For example, Cullen et al. (10) observed using macrophages isolated 
from human subjects with different apoE isoforms, that apoE4 macrophages effluxed less 
cholesterol than apoE2 or apoE3 and suggested that a combination of enhanced uptake and 
degradation of apoE4 by macrophages leads to lower cholesterol efflux. Similarly, in a 
murine macrophage cell line, Hara et al. demonstrated that adenovirus-mediated expression 
of apoE isoforms reduced cellular cholesterol in a manner inversely proportional to the 
LDLr affinity of apoE (26). Effects of LDLr were not investigated in either study by Cullen 
et al. (10) or Hara et al. (26).
The apoE3 and apoE2 proteins carry either one or two free cysteinyl groups, respectively, 
and may function as a better antioxidant than apoE4 protein, which does not have a free 
cysteinyl group. It has been shown in vitro that lipoprotein oxidation is apoE isoform-
dependent (9,16). Similarly, we show that lipid peroxidation in vitro by Cu2+ of mouse 
VLDL particles enriched with apoE4 is more susceptible to lipid peroxidation than particles 
with apoE3 or apoE2. However, we were not able to demonstrate the antioxidant effects of 
apoE in vivo. Antioxidant effects of apoE in vivo are likely to be small. Nevertheless, 
differences in the antioxidant capacity of apoE isoforms could be significant when excess 
oxidative stress is applied, such as in lipid-loaded macrophages in the atherosclerotic 
plaques.
Many of the functions of apoE in vascular tissues are isoform-specific and have been 
implicated as contributing factors to the well established increased atherosclerosis risk 
associated with apoE4 in humans. For example, apoE has been shown to inhibit smooth 
muscle cell proliferation, with apoE4 being less effective than apoE2 or apoE3 (27). This 
antiproliferative function may also be related to isoform-dependent nitric oxide release (28). 
ApoE has been shown to reduce atherosclerosis when expressed in the arterial wall without 
affecting lipid levels (29). Human apoE3 expressed in macrophages binds LDLr and is 
internalized, and a proportion of the internalized apoE is recycled in both hepatocytes and 
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macrophages (30, 31). Consistent with its increased LDLr affinity, apoE4 recycling is 
impaired relative to apoE3 in hepatocytes (24). Decreased recycling of apoE4 in the 
subendothelial space of blood vessels could result in prolonged retention and modification of 
lipoproteins. In contrast, apoE3 and apoE2 may exert their antiatherosclerotic effects 
multiple times if recycled back to the intimal space.
Macrophage LDLr metabolizes LDL and VLDL/chylomicron remnants (1, 15, 32, 33), and 
uptake of LDL by macrophages through the LDLr can induce foam cell formation in culture 
(32, 34). Thus, previous studies have shown that WT mice that received BM cells with WT 
LDLr develop larger diet-induced plaques compared with the WT mice that received cells 
lacking LDLr (18, 34). However, macrophage expression of the LDLr did not significantly 
increase atherosclerosis in the hyperlipidemic setting of LDLr−/− mice recipients when their 
macrophages expressed WT LDLr (11, 18, 35). All of these experiments used mice with 
wild type mouse apoE and LDLr. We now show, in the present paper, that the proatherogenic 
effects of human apoE4 isoform are LDLr expression-dependent even under the severe 
hyperlipidemic setting. Mice with apoE3 showed no difference in atherosclerosis when 
macrophage LDLr expression level was changed under the same hyperlipidemic condition.
Together, our results show that there is an important interaction between the apoE genotypes 
and LDLr expression levels in macrophages in determining cholesterol regulation in the cell 
(Fig. 7). Thus, the higher LDLr binding affinity of apoE4 increases cholesterol delivery to 
macrophages compared with apoE3. This effect is enhanced when lipoprotein particles are 
enriched with apoE4. The proatherogenic effects of apoE4 are further enhanced by a 
reduction in sterol efflux that is also apoE4-specific and LDLr-dependent. This is 
particularly important when cholesterol acceptors, such as HDL and apoA-I, are reduced in 
hyperlipidemia. Additionally, the reduced capacity of apoE4 to protect lipoproteins from 
oxidation compared with that of apoE3 could increase the atherogenicity of apoE4-
containing lipoproteins. Although differences in the individual effects of apoE4 compared 
with apoE3 are small, the combined effects are of importance and probably contribute to the 
adverse effects of apoE4 on plaque development in an LDLr-dependent fashion in 
macrophages. A similar mechanism is likely to operate in humans during the development of 
atherosclerosis.
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Figure 1. Expression of the Ldlr gene in the primary culture of mouse peritoneal macrophages
MPM from 3m, 3h, 4m, and 4ko mice were cultured in lipid free F-10 medium with or 
without 50 μg/ml VLDL isolated from apoE-deficient mice for 16 h. Total mRNA amount 
for the Ldlr gene was measured by RT-PCR, using the exon 1 sequence that is common 
between wild type mouse allele and hLdlr allele, normalized with the β-actin expression and 
plotted as expression levels relative to 3m equal to 1. The white bars indicate expression in 
cells cultured with VLDL, and black bars indicate without VLDL. *, p ≤ 0.05; ***, p ≤ 
0.0005 for effect of VLDL. ###, p ≤ 0.0005 for the effect of LDLr with Tukey-Kramer HSD.
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Figure 2. Lipoprotein uptake
A, MPM from 4ko, 4m, and 4h mice were cultured and incubated for 2 h with 1 μg/ml DiI-
labeled human LDL Cells were washed three times with PBS, and fluorescent intensity was 
measured using NIH Image J. MPM from 3ko, 3h,4ko, and 4h mice were incubated for 2 h 
with 1 μg/ml each of DiI-labeled 3ko VLDL(B)or4ko VLDL(C). Pixel intensities reflecting 
VLDLuptake were measured from four wells per experiment with cells pooled from at least 
three mice of each group, and averages of three experiments are shown as mean uptake of 
3ko cells as 100%. Effect of VLDL is as follows: *, p≤ 0.05; ***, p ≤ 0.0005 with Tukey-
Kramer HSD.
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Figure 3. Cholesterol efflux from MPM
Thioglycolate-elicited MPM were isolated from mice and incubated with [3H]cholesterol for 
24 h. Cells were then washed and incubated 24 h in medium without fetal bovine serum (A) 
or with the same medium containing 10/ng/ml apoA-I for 24 h (B). Radiolabel in medium 
and the cellular isopropyl alcohol extract were quantified, and the percentage of efflux was 
calculated as the ratio of radioactivity in the medium divided by total radioactivity (cells + 
medium) × 100%. Data are mean ± S.E. for three mice of the indicated genotypes assayed in 
quadruplicate. C, cholesterol efflux from MPM loaded with 50 μg/ml AcLDL and 
[3H]cholesterol for 24 h. D, ApoE that is cell-associated or secreted into culture medium 
from MPM incubated for 24 h in lipid-free medium.*, p≤ 0.05;**, p ≤ 0.005;***, p ≤ 
0.0005.
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Figure 4. VLDL oxidation
A, VLDL from 3ko and 4ko mice (1 μg) was incubated with 10 μM Cu2+. The ordinate 
shows lag time (average of three experiments) until the inflection point on 234 nm 
absorption curves. B, TBARS after Cu2+ oxidation of VLDL isolated from 3ko and 4ko 
mice. TBARS were measured after 16 h of incubation with 10 μM Cu2+ at 0.5 mg protein/ml. 
C, TBARS in the medium of MPM incubated with VLDL in culture. Thioglycolate-elicited 
MPM isolated from either 4ko or 3ko mice was incubated with 50 μg/ml apoE-deficient 
VLDL. TBARS in medium were measured after 24 h. *, p ≤ 0.05; **, p ≤ 0.005; ***, p ≤ 
0.0005 with Tukey-Kramer HSD.
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Figure 5. Bone marrow transfer
A, verification of bone marrow engraftment. DNA was isolated from buffy coat cells of 
recipient mice, and LDLr genotype was determined by multiplex PCR. The first seven lanes 
were recipients of ko cells showing a single PCR fragment. The next six lanes were 
recipients of hLdlr cells showing two bands; the upper band corresponds to the wild type 
mouse Ldlr allele, and the lower band corresponds to the hLdlr allele. The last four lanes are 
recipients of m-Ldlr cells showing only the wild type allele. No bands corresponding to the 
ko allele were detected in the recipients of h or m cells. B, macrophage LDLr mRNA level. 
Thioglycolate-elicited peritoneal cells were collected from bone marrow transfer recipients. 
Real time quantitative PCR was used for LDLr mRNA levels using exon 1 sequence that is 
common to hLdlr and wild type alleles. Averages from mice are shown relative to the 
expression of 3m donor. **, p ≤ 0.005; ***, p ≤ 0.0005. C, lipoprotein distribution in plasma 
isolated from the 3ko or 4ko recipient mice that received BM cells with different LDLr 
expression levels. Plasma (100 μl) pooled from at least five mice of each group was size-
fractionated on a fast protein liquid chromatography Superose 6 column, and the cholesterol 
and triglyceride contents of each fraction were measured with an enzymatic assay.
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Figure 6. Atherosclerotic lesions
Mean aortic sinus atherosclerotic lesion areas of 3ko mice that received 3m, 3h, and 3ko BM 
cells and of 4ko mice that received 4m, 4h, and 4ko BM cells are shown. *, p≤ 0.05 (4ko 
versus 4h); #, p ≤ 0.01 (3h versus 4h) with Tukey-Kramer HSD.
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Figure 7. Hypothetical interactions between macrophage LDLr and apoE isoforms in mice that 
underwent BMT
Increasing LDLr results in increased macrophage uptake of apoE containing VLDL and 
LDL (solid arrow). The relative uptake of apoE3-containing lipoproteins (A) is less than the 
uptake of apoE4 containing lipoproteins (B). Elevated LDLr reduced efflux in macro-phages 
that were loaded with cholesterol as well as unloaded apoE4 macro-phages (open arrow). 
ApoE3 has greater antioxidant capacity than apoE4. The antioxidant capacity increases as 
more apoE is retained by LDLr (shaded arrow). Overall, the combined effects are balanced 
in apoE3 macrophages, and their atherogenicity is not influenced by LDLr expression. In 
contrast, the combined effects are not balanced in apoE4 macrophage, and the atherogenicity 
is increased as LDLr expression increases.
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3m Apoe3/3, Ldlr+/+ Human apoE3
3h Apoe3/3, Ldlrh/+ Human apoE3 and increased LDLR
3ko Apoe3/3, Ldlr−/− Human apoE3 and no LDLR
4m Apoe4/4, Ldlr+/+ Human apoE4
4h Apoe4/4, Ldlrh/+ Human apoE4 and increased LDLR
4ko Apoe4/4, Ldlr−/− Human apoE4 and no LDLR
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Table 3
Plasma lipids and atherosclerosis in LDLr−/− mice expressing human apoE3 or apoE4 fed 
a NC diet
Male 3ko Female 3ko Male 4ko Female 4ko
Number 11 12 12 12
TC (mg/dl) 241 ± 18 386 ± 12 313 ± 25 427 ± 32
TG (mg/dl) 109 ± 12 102 ± 6 225 ± 22 114 ± 2
Lesion size (103 μm2) 13.4 ± 3.1 55.5 ± 7.2 12.0 ± 2.7 71.0 ± 14.4
Occlusion (%) 1.3 ± 0.3 5.1 ± 0.5 1.0 ± 0.2 5.4 ± 0.8
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